SB 2499 — Tennessee
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.
Tennessee legislative agenda & upcoming votes Tennessee session calendar
Summary
- SB 2499 is a bill in the Tennessee Senate, 114 session, introduced February 2, 2026.
- Sponsored by Kyle.
- Current status: introduced.
- Most recent action (March 10, 2026): Assigned to General Subcommittee of Senate Commerce and Labor Committee.
- Subjects: TennCare.
-
State Senator, District 30
Democratic
Contact your legislator about this bill
Bill text & documents
Sponsors
Primary: Kyle
History
- Introduced, completed
- Passed Senate, in progress
- Passed House, not reached yet
- Sent to Governor, not reached yet
- Signed into law, not reached yet
- Senate Refer to Senate Delayed Bills Committee
- Senate Filed for introduction
- Senate Introduced, Passed on First Consideration Milestone
- Senate Approved by Delayed Bills Committee
- Senate Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
- Senate Passed on Second Consideration, refer to Senate Commerce and Labor Committee
- Senate Assigned to General Subcommittee of Senate Commerce and Labor Committee Latest